To investigate whether the regulation of BCL2L12 splicing by BUD31 mediate the oncogenic role of BUD31 in ovarian cancer, we first analyzed TCGA data and found that BCL2L12 was positively correlated with BUD31 (Fig. 7a). This evidence concerns the gene BCL2L12 and ovarian cancer.